hotspot -WSS

hotspot

author：entertainment 2025-09-29 01:09:22 - browse：614

Seng Cheng has been working in gene therapy for nearly as long as gene therapy has been a field. As a young scientist in the early 1990s, he was part of one of three teams racing to develop a gene therapy for cystic fibrosis, a high-profile effort that resulted in national headlines, prestigious publications, and zero patients cured.

So he’s seen the field’s highs and lows. Lately, there have been a lot of both, including at Pfizer, the company Cheng called home until this summer. The pharma brought three potentially powerful gene therapies for muscular dystrophy and hemophilia into late-stage trials but, in January, chose to abandon a large portfolio of early stage candidates that relied on the same technology: adeno-associated viruses, or AAVs, a group of small bugs that scientists spent two decades taming into a gene shipping system.

The move seemed emblematic. Across the industry, AAV companies have been struggling, either shelving programs or stopping work altogether, while investors shuttled money toward new technologies such as CRISPR and its various permutations. Longtime researchers feared promising drugs, particularly for ultra-rare diseases, might get lost in the shuffle.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Truvian presents data for its desktop blood

leisure time

WSS

'Investigate these claims': UFO transparency at center of House hearing

New research sheds light on how often breast cancer is overdiagnosed

How doctors’ personal politics affect patients

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Rise in cancer among younger people worries and puzzles doctors

What it's like to live with paralysis for one psychologist

leisure time

hotspot

hotspot

Jerome Adams on the need for new antivirals for Covid

Roche’s Alnylam deal shows drug firms interested in heart drugs

Guidelines to prevent youth baseball injuries need more muscle

Democrats decry new health bill for going easy on private equity

Peter Hotez and the public health issue of online harassment

New lawsuit accuses health insurer Cigna of denying claims in bulk

Hollywood unions extend contract negotiations for actors

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Medical leaders decry Supreme Court decision on affirmative action

Congress: Prevent baby formula shortages by passing a new bill

explore

Pharma’s losing bet in New Jersey

Lawsuit challenges CMS nursing home minimum staffing rule

UHS says company favors patients whose insurance pays more

Pharma’s losing bet in New Jersey

Dems pitch expanding Medicare power to negotiate drug prices

Medical students need to learn the potent medicine of empathy

hotspot

leisure time

hotspot

hotspot